CStone presents preliminary results from a phase Ib study of the anti-CTLA-4 monoclonal antibody (mAb) CS1002 in combination with the anti-PD-1 mAb CS1003 in patients with advanced solid tumors at ESMO 2021

PR Newswire
September 19, 2021 — 09:00 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: China Congress European Expansion healthcare stock market Suzhou taiwan

Related News:

LG STRENGTHENS EUROPEAN PRESENCE WITH ITS KITCHEN SOLUTIONS SHOWCASE AT MDW 2024

April 18, 2024 — 09:00

National University of Singapore’s IES, The Rockefeller Foundation Advance Renewable Energy Connectivity in Southeast Asia

April 18, 2024 — 09:00

BitoGroup’s Strategic Expansion Doubles Market Reach in Taiwan

April 17, 2024 — 18:30

Students from JA Greece Win 2024 De La Vega Global Entrepreneurship Award

April 17, 2024 — 03:00

Bridgewise secures $21 million in new funding to support the global expansion of its AI-powered financial intelligence platform for global securities

April 16, 2024 — 12:01

International Film Camp Awards Winners

April 15, 2024 — 14:19

Pioneering Cutting-Edge Technologies: High-End Medical Imaging Developer VITAL HealthCare Debuts at CMEF

April 13, 2024 — 20:00

IOT Data Hackathon Award Ceremony – Data-driven Economy: Unleashing the Powerhouse of Possibilities

April 13, 2024 — 18:30

Goldpac Exhibits at InnoEx 2024

April 13, 2024 — 10:00